Filing Details

Accession Number:
0001181431-12-049080
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-06 17:46:21
Reporting Period:
2012-09-04
Filing Date:
2012-09-06
Accepted Time:
2012-09-06 17:46:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Biosciences Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234387 William John Larson C/O Sangamo Biosciences Inc.
Point Richmond Tech Cntr, 501 Canal Blvd
Richmond CA 94804
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-04 100 $5.20 268,060 No 4 S Direct
Common Stock Disposition 2012-09-04 601 $5.21 267,459 No 4 S Direct
Common Stock Disposition 2012-09-04 500 $5.22 266,959 No 4 S Direct
Common Stock Disposition 2012-09-04 100 $5.23 266,859 No 4 S Direct
Common Stock Disposition 2012-09-04 100 $5.24 266,759 No 4 S Direct
Common Stock Disposition 2012-09-04 299 $5.25 266,460 No 4 S Direct
Common Stock Disposition 2012-09-04 1,068 $5.26 265,392 No 4 S Direct
Common Stock Disposition 2012-09-04 429 $5.27 264,963 No 4 S Direct
Common Stock Disposition 2012-09-04 2,702 $5.30 262,261 No 4 S Direct
Common Stock Disposition 2012-09-04 803 $5.31 261,458 No 4 S Direct
Common Stock Disposition 2012-09-04 7,603 $5.32 253,855 No 4 S Direct
Common Stock Disposition 2012-09-04 196 $5.32 253,659 No 4 S Direct
Common Stock Disposition 2012-09-04 300 $5.33 253,359 No 4 S Direct
Common Stock Disposition 2012-09-04 99 $5.34 253,260 No 4 S Direct
Common Stock Disposition 2012-09-04 100 $5.35 253,160 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2012.